Association of p53 arginine polymorphism with skin cancer

被引:24
作者
de Oliveira, WRP
Rady, PL
Grady, J
Hughes, TK
Neto, CF
Rivitti, EA
Tyring, SK
机构
[1] Univ Sao Paulo, Dept Dermatol, Sao Paulo, Brazil
[2] Univ Texas, Med Branch, Dept Microbiol Immunol, Galveston, TX 77550 USA
[3] Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77550 USA
[4] Univ Texas, Med Branch, Dept Dermatol, Galveston, TX 77550 USA
关键词
D O I
10.1111/j.1365-4632.2004.02289.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The presence of arginine at codon 72 in p53 protein is proposed to be a genetic risk factor in human papillomavirus (HPV)-related carcinogenesis. Objective To study the prevalence of p53 polymorphism at codon 72 in skin biopsies of epidermodysplasia verruciformis (EV) patients compared to DNA samples from healthy individuals. Patients and methods DNA samples extracted from normal skin and tumor biopsies of 22 Brazilian patients with EV and blood samples from 27 healthy Brazilian individuals were studied for p53 codon 72 polymorphisms using restriction fragment length polymorphism (RFLP) analysis. Results All EV patients with the malignant form of EV were homozygous for arginine (Arg/Arg) at codon 72 of the p53 gene, in contrast to none with the benign form (P < 0.0001). Conclusions p53 arginine polymorphism is likely to be associated with the development of skin malignancies in EV patients from Brazil.
引用
收藏
页码:489 / 493
页数:5
相关论文
共 33 条
[1]   Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of Epidermodysplasia verruciformis-associated human papillornavirus type 8 [J].
Akgül, B ;
Karle, P ;
Adam, M ;
Fuchs, PG ;
Pfister, HJ .
VIROLOGY, 2003, 308 (02) :279-290
[2]  
Bastiaens MT, 2001, MOL CARCINOGEN, V30, P56, DOI 10.1002/1098-2744(200101)30:1<56::AID-MC1013>3.0.CO
[3]  
2-2
[4]   IS P53 POLYMORPHISM MAINTAINED BY NATURAL-SELECTION [J].
BECKMAN, G ;
BIRGANDER, R ;
SJALANDER, A ;
SAHA, N ;
HOLMBERG, PA ;
KIVELA, A ;
BECKMAN, L .
HUMAN HEREDITY, 1994, 44 (05) :266-270
[5]   Human papillomavirus infections in skin cancers [J].
de Villiers, EM .
BIOMEDICINE & PHARMACOTHERAPY, 1998, 52 (01) :26-33
[6]  
Dokianakis DN, 2000, INT J MOL MED, V5, P405
[7]   A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential [J].
Elbel, M ;
Carl, S ;
Spaderna, S ;
Iftner, T .
VIROLOGY, 1997, 239 (01) :132-149
[8]  
IFSTNER T, 1988, J VIROL, V62, P3655
[9]  
Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157
[10]   Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? [J].
Majewski, S ;
Jablonska, S .
ARCHIVES OF DERMATOLOGY, 2002, 138 (05) :649-654